GLP-1 and medical weight-loss care
Find a clinic that actually offers GLP-1 care.
We read clinic websites so you don’t have to. A clinic is listed for GLP-1 care only when its own site says so, and we show you the sentence.
1,210 clinics confirm GLP-1 or weight-management care, out of 3,355 listed across all 50 states and DC. Last checked September 20, 2026.
Evidence, not keywords
Each claim (semaglutide, tirzepatide, telehealth, accepting new patients) comes with the quote from the clinic’s website, the page it came from and the date we checked.
Local and online
Every state page also lists online prescribers whose own websites say they serve that state. We never assume a company is national.
No accounts, no intake
Search with a ZIP code. We don’t ask for your name, health history or insurance, and we don’t give medical advice.
Browse by state
- Alaska0
- Alabama10
- Arkansas5
- Arizona28
- California39
- Colorado97
- Connecticut5
- District of Columbia0
- Delaware3
- Florida124
- Georgia38
- Hawaii2
- Iowa10
- Idaho17
- Illinois25
- Indiana16
- Kansas13
- Kentucky11
- Louisiana5
- Massachusetts10
- Maryland17
- Maine12
- Michigan25
- Minnesota8
- Missouri24
- Mississippi5
- Montana8
- North Carolina41
- North Dakota1
- Nebraska6
- New Hampshire2
- New Jersey10
- New Mexico13
- Nevada16
- New York60
- Ohio33
- Oklahoma29
- Oregon17
- Pennsylvania24
- Rhode Island2
- South Carolina16
- South Dakota0
- Tennessee21
- Texas255
- Utah11
- Virginia24
- Vermont1
- Washington39
- Wisconsin23
- West Virginia2
- Wyoming7
Numbers are clinics confirming GLP-1 or weight-management care on their own websites.
By medication
- Semaglutide in Arizona
- Semaglutide in California
- Semaglutide in Colorado
- Semaglutide in Florida
- Semaglutide in Georgia
- Semaglutide in Illinois
- Semaglutide in Kansas
- Semaglutide in Maryland
- Semaglutide in Michigan
- Semaglutide in Missouri
- Semaglutide in North Carolina
- Semaglutide in New Jersey
- Semaglutide in New Mexico
- Semaglutide in Nevada
- Semaglutide in New York
- Semaglutide in Oklahoma
- Semaglutide in Pennsylvania
- Semaglutide in Tennessee
- Semaglutide in Texas
- Semaglutide in Virginia
- Semaglutide in Washington
- Tirzepatide in Arizona
- Tirzepatide in California
- Tirzepatide in Colorado
- Tirzepatide in Florida
- Tirzepatide in Georgia
- Tirzepatide in Illinois
- Tirzepatide in Maryland
- Tirzepatide in Michigan
- Tirzepatide in Missouri
- Tirzepatide in North Carolina
- Tirzepatide in Nevada
- Tirzepatide in New York
- Tirzepatide in Oklahoma
- Tirzepatide in Oregon
- Tirzepatide in Pennsylvania
- Tirzepatide in Tennessee
- Tirzepatide in Texas
- Tirzepatide in Washington
Guides
- Is compounded semaglutide or tirzepatide still legal?
Shortage end dates, 503A vs 503B rules, FDA's 2025–2026 enforcement actions, and warning signs to watch for with compounded GLP-1s.
- Wegovy vs Zepbound vs compounded GLP-1s: what's the difference?
A factual comparison of Wegovy, Zepbound, the Foundayo pill and compounded semaglutide or tirzepatide: ingredients, FDA status and approved uses.
- Brand-name GLP-1 self-pay options: LillyDirect, NovoCare and TrumpRx
Cash prices for Zepbound, Foundayo and Wegovy from LillyDirect, NovoCare and TrumpRx as of September 2026, and how self-pay differs from insurance.
- Does insurance, Medicare or Medicaid cover GLP-1 weight-loss drugs?
How Medicare Part D, the Medicare GLP-1 Bridge, the BALANCE Model, Medicaid and employer plans treat obesity GLP-1s, as of September 2026.
- Telehealth or a local clinic for GLP-1 care?
A neutral comparison of telehealth and in-person GLP-1 care: labs, exams, follow-up, continuity, state licensing rules and how programs charge.
- My telehealth provider shut down or stopped serving my state: how to continue GLP-1 care
What to do if your telehealth GLP-1 provider closes or leaves your state: get your records, avoid unsafe changes, and find a new prescriber.
- How to check a compounding pharmacy's license
Official license lookups for Texas, Colorado and New York, FDA's 503B outsourcing facility list, NABP tools, and red flags to watch for.